76.7 F
San Diego
Saturday, Jul 13, 2024
-Advertisement-

Halozyme Moving to the Nasdaq

Executives at Halozyme Therapeutics Inc. expect company stock to begin trading on the Nasdaq exchange May 10.

The biotechnology company is already publicly traded on the American Stock Exchange under the symbol HTI, and said April 30 that it expects to trade on the Nasdaq as HALO.

Halozyme has two products approved by the Food and Drug Administration used to help absorption of injected drugs, Cumulase and Hylenex.

Stock traded at midday April 30 at $10.20, down 18 cents or 1.73 percent from the closing price on the previous trading day.

, Katie Weeks

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-